Dr. Pazdur’s decision comes just weeks after being appointed as the head of CDER earlier in November this year.His ...

The main takeaway is that GLP-1s appear to provide kidney protection in a specific, well-defined population, CKD driven by ...

Rising healthcare costs are causing insured patients to avoid medical care, leading to poorer health outcomes and increased financial stress. Insurance premiums are increasing while coverage decreases ...

As patient-centric evidence continues to shape the future of drug development, challenges around increased complexity and regulatory scrutiny must be addressed.

Eli Lilly has announced a price reduction for Zepbound single-dose vials, targeting improved affordability for self-pay ...

New data shows that China and the US dominate breast cancer clinical trial expertise while lower-income countries remain ...

Many PBMs are also finding their business at risk as pharma–PBM tension continues to intensify. We predict that this tension will continue in 2026, especially for companies with late-stage assets in ...